Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects

Tenofovir is the representative treatment for human immunodeficiency virus and hepatitis B virus infection. This study was conducted to assess the pharmacokinetics (PKs) and safety characteristics after a single administration of tenofovir disoproxil phosphate compared to tenofovir disoproxil fumara...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sangmi, Kim, Eunwoo, Moon, Seol Ju, Jung, Jina, Lee, SeungHwan, Yu, Kyung-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020360/
https://www.ncbi.nlm.nih.gov/pubmed/33855000
http://dx.doi.org/10.12793/tcp.2021.29.e4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020360/
https://www.ncbi.nlm.nih.gov/pubmed/33855000
http://dx.doi.org/10.12793/tcp.2021.29.e4

Ejemplares similares